Syneos Health

FEBRUARY 21, 2020

We bring deep experience managing these challenges to each Cell and Gene Therapy (CGT) engagement, supported by the Syneos Health Cell and Gene Therapy Consortium, the hub for our knowledge and

Gene Therapy 52

Gene Therapy Gene 52

ECRG Media's Clinical Research Podcast

FEBRUARY 19, 2020

Interview With A CRA About Differences Working for Sponsor and CRO In this episode I interview a CRA and friend of mine about the differences of working for a Contract Research Organization (CRO) and a Sponsor. We dive into the differences between working for a company like Johnson and Johnson or Roche versus a company like Parexel or IQVIA. What are the challenges that a CRA might face.

Research 52

Research 52

Pharmacy Checkers

FEBRUARY 21, 2020

On behalf of Prescription Justice, I submitted comments to the FDA in response to its request for public comments on its draft guidance called: “Importation of Certain FDA-Approved Human Prescription Drugs, Including Biological Products, under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act: Draft Guidance for Industry.”. I published the comments in their entirety on Prescription Justice here: [link].

Drugs 61

Drugs FDA Approval Manufacturing Pharmacy 61

Drug Patent Watch

FEBRUARY 17, 2020

One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation. They open with the statement that “The novelty, effectiveness and…. The post Customer Success: DrugPatentWatch for Your Library appeared first on DrugPatentWatch - Make Better Decisions.

69

69

Advertisement

Clinical Supply

ECRG Media's Clinical Research Podcast

FEBRUARY 19, 2020

Interview With A CRA About Differences Working for Sponsor and CRO In this episode I interview a CRA and friend of mine about the differences of working for a Contract Research Organization (CRO) and a Sponsor. We dive into the differences between working for a company like Johnson and Johnson or Roche versus a company like Parexel or IQVIA. What are the challenges that a CRA might face.

Research 52

Research 52